COVAXIN is well tolerated with no serious adverse events in Phase I trials
The trial was conducted on volunteers from diverse geographic locations and socioeconomic conditions, enrolling 375 participants…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVAXIN
COVID-19 expedites India’s focus on innovation within pharma: GlobalData
According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020
Team of 70 Ambassadors and High Commissioners visit Bharat Biotech, discuss COVAXIN
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and…
Bharat Biotech seeks EUA for Covaxin
No date has been fixed as on when the SEC will meet for assessing and evaluating the applications, as per sources
Modi visits key vaccine facilities as COVID-19 case load surges
The Prime Minister Narendra Modi toured three of the nation’s leading vaccine development and manufacturing sites on Saturday as…
Homegrown COVID-19 vaccine final trials may conclude within two months: India
ICMR and Bharat Biotech month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers
Bharat Biotech commences Phase III trials for COVAXIN
Phase III trials will involve 26,000 volunteers across India who will receive two intramuscular injections, approximately 28 days…
AMU targets 1000 volunteers for phase-III trial of Covaxin
Volunteers will be given transportation, and other care, as well as precautions, will be taken, as endorsed in the guidelines for…
Covaxin may get launched in February 2021: ICMR scientist
The company had earlier hoped to launch it only in the second quarter of next year.
Bharat Biotech plans Covaxin launch in second quarter of 2021, post requisite approvals
Immediate focus is to conduct Phase 3 trial successfully